A diagnostics company in Aberystwyth, which has developed two rapid screening tests, is looking to raise seed funding to take its new products to market.
Following an intellectual and commercial partnership, spinout firm from the University of Aberystwyth iOmics is looking raise £500,000 in a first seed funding round - giving it a £5m valuation.
Further funding is expected to be required during the financial year of 2023-2024.
